𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention

✍ Scribed by Nicola Zanesi; Yuri Pekarsky; Carlo M. Croce

Book ID
113808708
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
196 KB
Volume
591
Category
Article
ISSN
0027-5107

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Precise localization of the FHIT gene to
Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines
✍ S. Tiong Ong; Kwun M. Fong; Scott A. Bader; John D. Minna; Michelle M. Le Beau; πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 154 KB πŸ‘ 2 views

Chromosomal or allelic losses at 3p14 are common in a variety of human tumors, including those of the lung, breast, kidney, and head and neck. This suggests the existence of a tumor suppressor gene in this band. A promising candidate is the recently cloned FHIT gene, which spans the common fragile s

Gene-directed enzyme prodrug therapy for
Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease
✍ Rosetta Martiniello-Wilks; Allison Dane; Dale J. Voeks; Geetha Jeyakumar; Elin M πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 310 KB πŸ‘ 1 views

## Abstract ## Background Gene‐directed enzyme prodrug therapy (GDEPT) based on the __E. coli__ enzyme purine nucleoside phosphorylase (PNP) represents a new approach for treating slow growing tumours like prostate cancer (PCa). Expressed enzyme converts a systemically administered prodrug, fludar